BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 16826584)

  • 1. Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder.
    Wright JL; Porter MP; Li CI; Lange PH; Lin DW
    Cancer; 2006 Aug; 107(4):721-8. PubMed ID: 16826584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population based survival data on urachal tumors.
    Pinthus JH; Haddad R; Trachtenberg J; Holowaty E; Bowler J; Herzenberg AM; Jewett M; Fleshner NE
    J Urol; 2006 Jun; 175(6):2042-7; discussion 2047. PubMed ID: 16697798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder.
    Wright JL; Black PC; Brown GA; Porter MP; Kamat AM; Dinney CP; Lin DW
    J Urol; 2007 Dec; 178(6):2302-6; discussion 2307. PubMed ID: 17936803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of survival from urachal cancer: a Mayo Clinic study of 49 cases.
    Molina JR; Quevedo JF; Furth AF; Richardson RL; Zincke H; Burch PA
    Cancer; 2007 Dec; 110(11):2434-40. PubMed ID: 17932892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Korean patients with clinically localized urachal or non-urachal adenocarcinoma of the bladder.
    Cho SY; Moon KC; Park JH; Kwak C; Kim HH; Ku JH
    Urol Oncol; 2013 Jan; 31(1):24-31. PubMed ID: 21458312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 672 patients with acinar cell carcinoma of the pancreas: a population-based comparison to pancreatic adenocarcinoma.
    Wisnoski NC; Townsend CM; Nealon WH; Freeman JL; Riall TS
    Surgery; 2008 Aug; 144(2):141-8. PubMed ID: 18656619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment methods as a prognostic factor in eight patients with urachal carcinoma].
    Yamada T; Fukui I; Sekine H; Kihara K; Oshima H
    Hinyokika Kiyo; 1991 Feb; 37(2):113-6. PubMed ID: 2048489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy.
    Ashley RA; Inman BA; Sebo TJ; Leibovich BC; Blute ML; Kwon ED; Zincke H
    Cancer; 2006 Aug; 107(4):712-20. PubMed ID: 16826585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy.
    Wright JL; Lin DW; Porter MP
    Cancer; 2008 Jun; 112(11):2401-8. PubMed ID: 18383515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry.
    Stessin AM; Meyer JE; Sherr DL
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1128-33. PubMed ID: 18538501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder.
    Lane Z; Hansel DE; Epstein JI
    Am J Surg Pathol; 2008 Sep; 32(9):1322-6. PubMed ID: 18670358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urachal carcinoma: contemporary surgical outcomes.
    Herr HW; Bochner BH; Sharp D; Dalbagni G; Reuter VE
    J Urol; 2007 Jul; 178(1):74-8; discussion 78. PubMed ID: 17499279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary scrotal cancer: disease characteristics and increasing incidence.
    Wright JL; Morgan TM; Lin DW
    Urology; 2008 Nov; 72(5):1139-43. PubMed ID: 18799208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adenocarcinomas of the urachus].
    Salinas Sánchez AS; Alcalá-Santaella Casanova C; Martínez Martín M; Pastor Guzmán JM; Cañamares Pabolaza L; Virseda Rodríguez J
    Arch Esp Urol; 1991; 44(1):31-6. PubMed ID: 1648342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic features and utility of immunohistochemical markers in signet-ring cell adenocarcinoma of the bladder.
    Thomas AA; Stephenson AJ; Campbell SC; Jones JS; Hansel DE
    Hum Pathol; 2009 Jan; 40(1):108-16. PubMed ID: 18789486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of upper tract urothelial cell carcinoma after primary bladder cancer: a population based analysis.
    Wright JL; Hotaling J; Porter MP
    J Urol; 2009 Mar; 181(3):1035-9; discussion 1039. PubMed ID: 19150569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adenocarcinoma of the urinary bladder: a report of 27 cases].
    Shou J; Ma J; Xu B
    Zhonghua Zhong Liu Za Zhi; 1999 Nov; 21(6):461-3. PubMed ID: 11776628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary bladder adenocarcinoma: retrospective study of 11 cases and general review].
    Martínez-Piñeiro L; González-Peramato P; Hidalgo L; de la Peña J; Cisneros J; Cozar JM; Martínez-Piñeiro JA
    Arch Esp Urol; 1991 Mar; 44(2):131-8. PubMed ID: 1867487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bladder adenocarcinoma: 31 reported cases.
    Xiaoxu L; Jianhong L; Jinfeng W; Klotz LH
    Can J Urol; 2001 Oct; 8(5):1380-3. PubMed ID: 11718635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years.
    Bilimoria KY; Bentrem DJ; Wayne JD; Ko CY; Bennett CL; Talamonti MS
    Ann Surg; 2009 Jan; 249(1):63-71. PubMed ID: 19106677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.